The T-Type Ca2+ Channel Blocker Mibefradil Prevents the Development of a Substrate for Atrial Fibrillation by Tachycardia-Induced Atrial Remodeling in Dogs
Circulation - United States
doi 10.1161/01.cir.100.21.2191
Full Text
Open PDFAbstract
Available in full text
Date
November 23, 1999
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)